Key points are not available for this paper at this time.
Hepatitis C virus (HCV) burden is higher among people in prison given high prevalence of injecting drug use. This study evaluated direct-acting antiviral (DAA) treatment outcome in prisons.
Ryan et al. (Tue,) studied this question.